MedTrace Logo

Control of Colic in Infants by Dietary Supplementation With the Probiotic Lactobacillus Reuteri

NCT01067027 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2011-06-29

No results posted yet for this study

Summary

It is believed that probiotic Lactobacillus reuteri will improve the symptoms of breast-fed infants with colic.

Conditions

  • Colic

Interventions

DIETARY_SUPPLEMENT

Lactobacillus reuteri

5 drops of study product 30 minutes before feeding.

Sponsors & Collaborators

  • Children's Investigational Research Program, LLC

    lead OTHER

Principal Investigators

  • Bryan M Harvey, M.D. · Children's Investigational Research Program

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
SINGLE_GROUP

Eligibility

Min Age
14 Days
Max Age
60 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2011-12-31
Completion
2012-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01067027 on ClinicalTrials.gov